Construction of lentivirus-based inhibitor of hsa-microRNA-338-3p with specific secondary structure

Acta Pharmacologica Sinica

Volumn 34, Issue 1, 2013, Pages 167-175

  Sun, Kai ^a   Guo, Chen ^a   Deng, Hai Jun ^a   Dong, Jing Qing ^a   Lei, Shang Tong ^a   Li, Guo Xin ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

colorectal carcinoma; hsa miR 338 3p; lentivirus; microRNAs (miRNAs)

Indexed keywords

LENTIVIRUS VECTOR; MICRORNA; MICRORNA 338 3P; MICRORNA 338 3P INHIBITOR; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL MIGRATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BASE SEQUENCE; CELL LINE, TUMOR; COLON; COLORECTAL NEOPLASMS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HEK293 CELLS; HUMANS; LENTIVIRUS; MICRORNAS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; RECTUM; TRANSDUCTION, GENETIC;

EID: 84872092423     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2012.172     Document Type: Article

References (24)

1. Bartels CL, Tsongalis GJ. MicroRNAs: novel biomarkers for human cancer. Clin Chem 2009;55:623-31.
2. Mirnezami AH, Pickard K, Zhang L, Primrose JN, Packham G. MicroRNAs: key players in carcinogenesis and novel therapeutic targets. Eur J Surg Oncol 2009;35:339-47.
3. Torres AG, Fabani MM, Vigorito E, Williams D, Al-Obaidi N, Wojciechowski F, et al. Chemical structure requirements and cellular targeting of microRNA-122 by peptide nucleic acids anti-miRs. Nucleic Acids Res 2012;40:2152-67.
4. Ebert MS, Sharp PA. MicroRNA sponges: progress and possibilities. RNA 2010;16:2043-50.
5. Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007;4:721-6. (Pubitemid 47338166)
6. Ebert MS, Sharp PA. Emerging roles for natural microRNA sponges. Curr Biol 2010;20:858-61.
7. Stegmeier F, Hu G, Rickles RJ, Hannon GJ, Elledge SJ. A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. Proc Natl Acad Sci U S A 2005;102:13212-7. (Pubitemid 41325003)
8. Reichel M, Li J, Millar AA. Silencing the silencer: strategies to inhibit microRNA activity. Biotechnol Lett 2011;33:1285-92.
9. Aschrafi A, Schwechter AD, Mameza MG, Natera-Naranjo O, Gioio AE, Kaplan BB. MicroRNA-338 regulates local cytochrome c oxidase IV mRNA levels and oxidative phosphorylation in the axons of sympathetic neurons. J Neurosci 2008;28:12581-90.
10. Park F. Lentiviral vectors: are they the future of animal transgenesis? Physiol Genomics 2007;31:159-73. (Pubitemid 350014393)
11. Vermeulen A, Robertson B, Dalby AB, Marshall WS, Karpilow J, Leake D, et al. Double-stranded regions are essential design components of potent inhibitors of RISC function. RNA 2007;13:723-30. (Pubitemid 46641531)
12. Haraguchi T, Nakano H, Tagawa T, Ohki T, Ueno Y, Yoshida T, et al. A potent 2'-O-methylated RNA-based microRNA inhibitor with unique secondary structures. Nucleic Acids Res 2012;40:e58.
13. Tokusumi Y, Ma Y, Song X, Jacobson RH, Takada S. The new core promoter element XCPE1 (X Core Promoter Element 1) directs activator-, mediator-, and TATA-binding protein-dependent but TFIID-independent RNA polymerase II transcription from TATA-less promoters. Mol Cell Biol 2007;27:1844-58.
14. Sun K, Zeng JJ, Wang W, Wu CT, Lei ST, Li GX. MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma. Acta Pharmacol Sin 2011;32:375-84.
15. Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res 2004;14:1902-10. (Pubitemid 39386503)
16. Tsuchiya S, Oku M, Imanaka Y, Kunimoto R, Okuno Y, Terasawa K, et al. MicroRNA-338-3p and microRNA-451 contribute to the formation of basolateral polarity in epithelial cells. Nucleic Acids Res 2009;37:3821-7.
17. Huang XH, Wang Q, Chen JS, Fu XH, Chen XL, Chen LZ, et al. Beadbased microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is down-regulated. Hepatology Research 2009;39:786-94.
18. Hu B, Tai A, Wang P. Immunization delivered by lentiviral vectors for cancer and infectious diseases. Immunol Rev 2011;239:45-61.
19. Yue J. miRNA and vascular cell movement. Adv Drug Deliv Rev 2011;63:616-22.
20. Haraguchi T, Ozaki Y, Iba H. Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Nucleic Acids Res 2009;37:e43.
21. Scherr M, Venturini L, Battmer K, Schaller-Schoenitz M, Schaefer D, Dallmann I, et al. Lentivirus-mediated antagomir expression for specific inhibition of miRNA function. Nucleic Acids Res 2007;35:e149.
22. Wang K, Pan L, Che X, Cui D, Li C. Sonic Hedgehog/GLI1 signaling pathway inhibition restricts cell migration and invasion in human gliomas. Neurol Res 2010;32:975-80.
23. Huang XH, Chen JS, Wang Q, Chen XL, Wen L, Chen LZ, et al. miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened. J Pathol 2011;225:463-72.
24. Ventura A, Meissner A, Dillon CP, McManus M, Sharp PA, Van Parijs L, et al. Cre-lox-regulated conditional RNA interference from transgenes. Proc Natl Acad Sci U S A 2004;101:10380-5. (Pubitemid 38924934)